MedTrace Logo

Longitudinal HPV Pap in CIN and VAIN

NCT05931354 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-07-05

No results posted yet for this study

Summary

This study will construct a longitudinal risk model of VaIN according to the HPVs distribution of cervix and vaginal for those had CIN2+. The study will include three arms to complete the follow-up data for the previous cohort constructed, and prospectively recruit new subjects with the appropriate inclusion/excluding criteria in order to increase sample size of this study.

Conditions

  • Cervical Intraepithelial Neoplasia
  • Hysterectomy
  • Human Papillomavirus
  • Vaginal Intraepithelial Neoplasia

Interventions

OTHER

HPV test and Pap Smear

HPV test and Pap Smear

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05931354 on ClinicalTrials.gov